All In Biotech

Drug Trial Radar · NCT00529087

Study Evaluating Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation (OIC) in Subjects With Chronic Non-Malignant Pain

A Mulitcenter, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Study of Subcutaneous MOA-728 for the Treatment of Opioid-Induced Constipation in Subjects With Chronic Non-Malignant Pain

Last checked: Nov 19, 2026Latest source record: Nov 25, 2019 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. Randomized with 460 participants. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

460

Actual

Start

Aug 2007

Primary completion

Dec 2008

Study completion Dec 2008

Sponsor

Lead sponsor
Bausch Health Americas, Inc.Industry
Sponsor type
Industry
Collaborators
Progenics Pharmaceuticals, Inc.
First posted
Sep 14, 2007

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The primary purpose of the protocol is to evaluate the safety, efficacy, and tolerability of subcutaneous MOA-728 versus placebo in subjects with chronic non-malignant pain who have Opioid-Induced Constipation (OIC).

Conditions

  • Constipation

Interventions

  • N-methylnaltrexone bromide (MOA-728)Drug

    Subcutaneous

  • placeboOther

    placebo

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Percentage of Patients Having a Rescue-free Bowel Movement (RFBM) Within 4 Hours of the First DoseTime frame: up to 4 hours
  2. Percentage of Active Injections Resulting in Any Rescue-free Bowel Movement (RFBM) Within 4 Hours of Injection During the Double-blind PeriodTime frame: 4 weeks

Locations

78 sites in 1 country. Site status is shown where the registry gives one.

  • Site not named

    Mobile, Alabama

  • Site not named

    Mobile, Alabama

  • Site not named

    Sun City, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    Tucson, Arizona

  • Site not named

    Hot Springs, Arkansas

  • Site not named

    Anaheim, California

  • Site not named

    Garden Grove, California

  • Site not named

    Hawaiian Gardens, California

  • Site not named

    Long Beach, California

  • Site not named

    Los Angeles, California

  • Site not named

    San Diego, California

  • Site not named

    Brandon, Florida

  • Site not named

    Cheifland, Florida

  • Site not named

    Clearwater, Florida

  • Site not named

    Gainesville, Florida

  • Site not named

    Jacksonville, Florida

  • Site not named

    Jupiter, Florida

  • Site not named

    Largo, Florida

  • Site not named

    Miami, Florida

  • Site not named

    Naples, Florida

  • Site not named

    Ocala, Florida

  • Site not named

    Ocala, Florida

  • Site not named

    Orlando, Florida

  • Site not named

    Ormond Beach, Florida

  • Site not named

    Spring Hill, Florida

  • Site not named

    Tampa, Florida

  • Site not named

    West Palm Beach, Florida

  • Site not named

    Winter Park, Florida

  • Site not named

    Atlanta, Georgia

  • Site not named

    Marietta, Georgia

  • Site not named

    Stockbridge, Georgia

  • Site not named

    Chicago, Illinois

  • Site not named

    DeKalb, Illinois

  • Site not named

    Avon, Indiana

  • Site not named

    Indianapolis, Indiana

  • Site not named

    West Des Moines, Iowa

  • Site not named

    Shreveport, Louisiana

  • Site not named

    Sunset, Louisiana

  • Site not named

    Elkridge, Maryland

Showing 40 of 78 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.